Permeability classification of representative fluoroquinolones by a cell culture method
- 1 June 2004
- journal article
- Published by Springer Science and Business Media LLC in AAPS PharmSci
- Vol. 6 (2), 1-6
- https://doi.org/10.1208/ps060213
Abstract
This study was undertaken to categorize representative fluoroquinolone drug substance permeability based on the methods outlined in the Food and Drug Administration's biopharmaceutic classification system (BCS) Guidance for Industry. The permeability of ciprofloxacin, levofloxacin, lomefloxacin, and ofloxacin was measured in an in vitro Caco-2 assay with previously demonstrated method suitability. The permeability class and efflux potential were ascertained by comparing test drug results with standard compounds (metoprolol, atenolol, labetalol, and rhodamine-123). All 4 quinolones drugs demonstrated concentration-dependent permeability, indicating active drug transport. In comparing absorptive versus secretive in vitro transport, the tested fluoroquinolones were found to be subject to efflux in varying degrees (ciprofloxacin > lomefloxacin > rhodamine 123 > levofloxacin > ofloxacin). Based on comparison to labetalol, the high permeability internal standard, ciprofloxacin was classified as a low permeability drug, whereas lomefloxacin, levofloxacin, and ofloxacin were classified as high permeability drugs. The in vitro permeability results matched human in vivo data based on absolute bioavailabilities. This laboratory exercise demonstrated the applicability of an in vitro permeability method for classifying drugs as outlined in the BCS Guidance.Keywords
This publication has 10 references indexed in Scilit:
- Transintestinal secretion of ciprofloxacin, grepafloxacin and sparfloxacin: in vitro and in situ inhibition studiesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2003
- Transport characteristics of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2European Journal of Pharmacology, 2001
- CLINICAL USE OF THE FLUOROQUINOLONESMedical Clinics of North America, 2000
- Comparison of the Fluoroquinolones Based on Pharmacokinetic and Pharmacodynamic ParametersPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- Mode of Action of FluoroquinolonesDrugs, 1999
- Fluoroquinolone (ciprofloxacin) secretion by human intestinal epithelial (Caco‐2) cellsBritish Journal of Pharmacology, 1997
- A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo BioavailabilityPharmaceutical Research, 1995
- Active secretion of the fluoroquinolone ciprofloxacin by human intestinal epithelial Caco‐2 cell layersBritish Journal of Pharmacology, 1993
- Quinolone pharmacokinetics and metabolismJournal of Antimicrobial Chemotherapy, 1990
- Pharmacokinetics of Fluorinated QuinolonesPublished by Elsevier BV ,1988